Breaking News Instant updates and real-time market news.

TEVA

Teva

$24.21

0.1 (0.41%)

08:10
08/20/18
08/20
08:10
08/20/18
08:10

Teva Canada expands recall of valsartan drugs to include additional lots

Health Canada is advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight additional lots of valsartan products in Canada because they may contain an impurity, N-nitrosodimethylamine. Valsartan is used to treat high blood pressure and heart failure.This latest action is further to an initial recall of certain valsartan products because of the presence of NDMA in the active ingredient. All of the recalled products use a valsartan ingredient manufactured by Zhejiang Huahai Pharmaceuticals in China. Health Canada is reviewing the long-term potential health impacts of the NDMA impurity on patients. The additional Teva Canada products are being recalled after sample testing of the active ingredient by Zhejiang Huahai Pharmaceuticals identified trace levels of NDMA. Testing is ongoing. In the meantime, Health Canada has asked Teva Canada to recall these additional products as a precautionary measure, and to conduct a full investigation to determine the root cause of this most recent issue.

  • 10

    Sep

  • 12

    Sep

  • 16

    Sep

TEVA Teva
$24.21

0.1 (0.41%)

08/08/18
FBCO
08/08/18
NO CHANGE
FBCO
Credit Suisse remains cautiously optimistic on Teva's Fremanezumab approval
Credit Suisse analyst Vamil Divan believes Celltrion press releases and Teva's comments still point to September approval for Fremabezumab. While the analyst would certainly prefer a cleaner story heading into the Action Date, he is comfortable enough with the company comments to maintain a cautiously optimistic view.
08/16/18
PIPR
08/16/18
NO CHANGE
Target $450
PIPR
Overweight
Regeneron's fasinumab safety remains 'open question,' says Piper Jaffray
Piper Jaffray analyst Christopher Raymond backed an Overweight rating on Regeneron Pharmaceuticals (REGN) shares following this morning's release of fasinumab results, saying the drug and partner Teva's (TEVA) anti-NGF antibody met its primary and secondary efficacy pain and functional endpoints in a Phase 3 trial of patients with chronic pain from osteoarthritis of the knee or hip. Raymond says the efficacy "was never really in doubt," but the bigger focus for the drug is safety, and will wait for detailed data at an upcoming medical meeting, but notes that fasinumab's arthropathy rate appears "slightly higher" than that of tanezumab. Given the severity of the ongoing opioid epidemic and relative lack of alternatives for these patients outside of total joint replacement, the analyst thinks the appetite of regulators and potential market for new effective, non-opioid chronic pain therapies like anti-NGF clearly exists, though he will leave this as an unmodeled potential source of upside for now,
08/16/18
WELS
08/16/18
NO CHANGE
WELS
Market Perform
Teva's earlier than expected generic EpiPen bad news for Mylan, says Wells Fargo
Wells Fargo analyst David Maris said he believes the EpiPen generic seemed to have been thought of as a 2019 event by Mylan (MYL) and Teva (TEVA) investors, so the FDA approval today of the first generic EpiPen came earlier than expectations, which is both good news for Teva and negative news for Mylan. Mylan no longer breaks out the Specialty segment, so it is difficult to estimate how meaningful this is to the company, said Maris, but he believes "this is still an important product to Mylan." He keeps a Market Perform rating on Mylan shares, and for Teva calls the approval "a great addition for a company in need of good news."
08/17/18
HCWC
08/17/18
NO CHANGE
Target $4.5
HCWC
Buy
H.C. Wainwright ups Antares price target to $4.50 after generic EpiPen approval
After the FDA announced the "long-awaited" approval of Antares Pharma (ATRS) and partner Teva's (TEVA) generic EpiPen, H.C. Wainwright analyst Oren Livnat said his estimates include nearly $40M in peak EpiPen revenue to Antares from the "biggest partnered pipeline opportunity" the company has modeled by his and consensus estimates. Livnat, who said he is not aware of any other substitutable EpiPen generics on the way, views the product as a sustainable contributor and raised his price target on Antares shares to $4.50 from $4.00 following the news. Livnat, who assumes Teva launches quickly after final label packaging, but believes that Teva "unfortunately" will miss the big EpiPen back-to-school prescribing season, keeps a Buy rating on Antares shares.

TODAY'S FREE FLY STORIES

XYF

X Financial

$5.42

0.1 (1.88%)

17:34
05/20/19
05/20
17:34
05/20/19
17:34
Earnings
X Financial reports Q1 EPS 24c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

KTB

Kontoor Brands

$0.00

(0.00%)

, ORN

Orion Group

$2.31

0.02 (0.87%)

17:31
05/20/19
05/20
17:31
05/20/19
17:31
Hot Stocks
S&P announces changes to S&P SmallCap 600 index »

S&P Dow Jones Indices…

KTB

Kontoor Brands

$0.00

(0.00%)

ORN

Orion Group

$2.31

0.02 (0.87%)

VFC

VF Corp.

$90.70

-0.08 (-0.09%)

ARWR

Arrowhead

$18.94

-0.52 (-2.67%)

NAVG

Navigators

$69.99

-0.01 (-0.01%)

HIG

Hartford Financial

$53.13

-0.45 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

  • 11

    Jun

  • 13

    Nov

BYND

Beyond Meat

$86.10

-3.23 (-3.62%)

17:29
05/20/19
05/20
17:29
05/20/19
17:29
Hot Stocks
Beyond Meat appoints Teri Witteman as General Counsel and Secretary »

Beyond Meat announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ARWR

Arrowhead

$18.94

-0.52 (-2.67%)

, NAVG

Navigators

$69.99

-0.01 (-0.01%)

17:27
05/20/19
05/20
17:27
05/20/19
17:27
Hot Stocks
Arrowhead to replace Navigators in S&P 600 at open on 5/24 »

The Hartford Financial…

ARWR

Arrowhead

$18.94

-0.52 (-2.67%)

NAVG

Navigators

$69.99

-0.01 (-0.01%)

HIG

Hartford Financial

$53.13

-0.45 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

YGYI

Youngevity

$6.57

0.13 (2.02%)

17:25
05/20/19
05/20
17:25
05/20/19
17:25
Earnings
Breaking Earnings news story on Youngevity »

Youngevity backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTB

Kontoor Brands

$0.00

(0.00%)

, ORN

Orion Group

$2.31

0.02 (0.87%)

17:25
05/20/19
05/20
17:25
05/20/19
17:25
Hot Stocks
Kontoor Brands to replace Orion Group in S&P 600 at open on 5/24 »

V.F. Corp. (VFC) is…

KTB

Kontoor Brands

$0.00

(0.00%)

ORN

Orion Group

$2.31

0.02 (0.87%)

VFC

VF Corp.

$90.70

-0.08 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 06

    Jun

  • 13

    Nov

YGYI

Youngevity

$6.57

0.13 (2.02%)

17:25
05/20/19
05/20
17:25
05/20/19
17:25
Earnings
Youngevity reports Q1 EPS (49c), one estimate (1c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$169.34

2.95 (1.77%)

17:22
05/20/19
05/20
17:22
05/20/19
17:22
Hot Stocks
General Dynamics awarded $497.01M Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

ISRL

Isramco, Inc.

$110.20

-2.05 (-1.83%)

17:18
05/20/19
05/20
17:18
05/20/19
17:18
Hot Stocks
Isramco enters into $121.40 per share merger pact with Naphtha Israel Petroleum »

Isramco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

PotlatchDeltic

$36.17

-1.31 (-3.50%)

17:16
05/20/19
05/20
17:16
05/20/19
17:16
Hot Stocks
PotlatchDeltic announces changes to Idaho recreation permits »

PotlatchDeltic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

PEN

Penumbra

$139.05

-3.805 (-2.66%)

17:13
05/20/19
05/20
17:13
05/20/19
17:13
Initiation
Penumbra initiated at William Blair »

Penumbra assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 05

    Jun

ISRL

Isramco, Inc.

$110.20

-2.05 (-1.83%)

17:10
05/20/19
05/20
17:10
05/20/19
17:10
Hot Stocks
Breaking Hot Stocks news story on Isramco, Inc. »

Isramco, Inc. trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$34.71

0.27 (0.78%)

17:07
05/20/19
05/20
17:07
05/20/19
17:07
Hot Stocks
New York Times CEO sells 45,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KNL

Knoll

$20.78

0.025 (0.12%)

17:06
05/20/19
05/20
17:06
05/20/19
17:06
Hot Stocks
Knoll CEO sells 10.2K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$7.91

0.42 (5.61%)

, BX

Blackstone

$40.62

-0.1 (-0.25%)

17:04
05/20/19
05/20
17:04
05/20/19
17:04
Periodicals
QEP Resources considering sale after Elliott proposal, Bloomberg says »

QEP Resources (QEP) has…

QEP

QEP Resources

$7.91

0.42 (5.61%)

BX

Blackstone

$40.62

-0.1 (-0.25%)

WLL

Whiting Petroleum

$22.74

-0.75 (-3.19%)

CPE

Callon Petroleum

$7.62

-0.56 (-6.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 11

    Jun

USAT

USA Technologies

$5.90

-0.13 (-2.16%)

17:03
05/20/19
05/20
17:03
05/20/19
17:03
Hot Stocks
USA Technologies extends contract of interim CFO Glen Goold »

The company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAT

USA Technologies

$5.90

-0.13 (-2.16%)

17:02
05/20/19
05/20
17:02
05/20/19
17:02
Hot Stocks
USA Technologies receives additional Nasdaq deficiency notice »

USA Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVRO

Nevro

$60.05

-2.235 (-3.59%)

17:02
05/20/19
05/20
17:02
05/20/19
17:02
Hot Stocks
Nevro names D. Keith Grossman chairman of the board »

Nevro Corp. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

STZ

Constellation Brands

$203.04

-1.79 (-0.87%)

17:01
05/20/19
05/20
17:01
05/20/19
17:01
Periodicals
Constellation Brands gets 2nd FTC request over E.&J Gallo winery deal »

According to the Wall…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRS

Amyris

$4.09

-0.15 (-3.54%)

17:01
05/20/19
05/20
17:01
05/20/19
17:01
Hot Stocks
Amyris receives Nasdaq deficiency notification over delayed quarterly report »

Amyris, Inc. reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$11.19

-0.3 (-2.61%)

16:57
05/20/19
05/20
16:57
05/20/19
16:57
Hot Stocks
Snap names Derek Andersen new CFO, appoints Lara Sweet as Chief People Officer »

Snap announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SCON

Superconductor Technologies

$1.25

-0.065 (-4.94%)

16:52
05/20/19
05/20
16:52
05/20/19
16:52
Syndicate
Superconductor Technologies files to sell common stock, no amount given »

H.C. Wainwright & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

CCC

Clarivate Analytics

$13.34

-0.04 (-0.30%)

, INFO

IHS Markit

$57.51

0.12 (0.21%)

16:50
05/20/19
05/20
16:50
05/20/19
16:50
Hot Stocks
Clarivate Analytics names Jerre Stead as CEO, effective June 30 »

Clarivate Analytics (CCC)…

CCC

Clarivate Analytics

$13.34

-0.04 (-0.30%)

INFO

IHS Markit

$57.51

0.12 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$130.42

-4.8 (-3.55%)

16:50
05/20/19
05/20
16:50
05/20/19
16:50
Hot Stocks
Breaking Hot Stocks news story on Nordson »

Nordson down 2.7% at $127…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 05

    Jun

  • 13

    Jun

EBAY

eBay

$36.56

-0.34 (-0.92%)

16:47
05/20/19
05/20
16:47
05/20/19
16:47
Earnings
eBay VP Kristin Yetto sells over $940K shares of company stock »

eBay VP Kristin Yetto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.